Reset
Wednesday

Learning Objectives:

  • The basic concepts of pharmacokinetics and pharmacodynamics.
  • Describe the clinical implications of how drug disposition changes in the newborn period with maturation.
  • Apply basic PK principles to improve drug dosing to achieve targeted serum concentrations for desired effect.

Wednesday

Learning Objectives:

  • Describe recent pharmacokinetic findings in infants for antifungals.
  • Describe recent safety findings in infants for antifungals.
  • Describe recent dosing recommendation for treatment of Candida meningoencephalitis.

Speaker Disclosure:

Shionogi
Cempra
Abbvie

Speaker Relationship:

Contract
Contract
Consultant


Wednesday

Learning Objectives:

  • Review Postnatal Glucose Homeostasis and Transitional Neonatal Hyperinsulinemia.
  • Discuss approaches to define Hypoglycemia in the Neonate.
  • Learn strategies to screen and manage low glucose levels as well as address ways to identify Persistent Hypoglycemic Syndromes.

Wednesday

Learning Objectives:

  • Recognize at least 2 potential medication errors in the NICU.
  • Describe at least one practice to reduce medication errors in the NICU.
  • Describe how inattentional blindness can contribute to medication errors.

Wednesday

Learning Objectives:

  • Describe recent pharmacokinetic findings in infants for antibiotics.
  • Describe recent safety findings in infants for antibiotics.
  • Describe factors influencing choice of empirical antibiotic therapy for hospitalized infants.



Wednesday

Learning Objectives:

  • Determine the current definition of vitamin D health.
  • Identify the evidence regarding vitamin D status and vitamin D intake for infants.
  • Determine methods to optimize vitamin D health of hospitalized infants.



Wednesday

Learning Objectives:

  • Describe the mechanism of action of commonly used sedatives.
  • Describe the concern regarding neurodevelopmental outcome and medication exposure.
  • Identify differences in drug metabolism unique to neonates.



Wednesday

Learning Objectives:

  • Determine the evidence-based practice of preterm infant feeding.
  • Identify the evidence regarding additives to human milk.
  • Determine the most efficacious and safest methods to feed preterm infants.



Thursday

Learning Objectives:

  • Know survival rates for VLBW infants.
  • Be aware of risks and benefits of antenatal corticosteroids for late preterm infants.
  • Know the importance of preventing hemorrhagic disease of the newborn.

Thursday

Learning Objectives:

  • Review nutritional strategies with higher protein to energy ratios to prevent postnatal growth failure.
  • Evaluate the data on prevention of NEC with human milk, probiotics and lactoferrin.
  • Look at newer products and strategies to improve the fortification of human milk for VLBW infants.